Gene News and Research

Latest Gene News and Research

Scientists discover potential new genetic causes for intellectual disability

An international group of researchers has for the first time identified a set of 30 inherited recessive genes that play a role in intellectual disability (ID), a neurodevelopmental disorder that, according to the Centers for Disease Control, affects as many as 213 million people around the world.

9 Sep 2016

Fruit flies hold clues to how cancerous tumors get started

A Florida State University research team, in coordination with a team from Japan, has found that the epithelial tissues that line the surfaces of organs throughout the body intrinsically have hot spots for cancerous tumors.

9 Sep 2016

New mouse model helps identify potential drug target for hard-to-treat social aspects of ASD

A study of a new mouse model identifies a drug target that has the potential to increase social interaction in individuals with some forms of autism spectrum disorder (ASD), according to researchers in the Perelman School of Medicine at the University of Pennsylvania. The team published their work in Biological Psychiatry.

9 Sep 2016

Interactions between rare and common genetic variants may contribute to craniosynostosis

During the first year of life, the human brain doubles in size, and continues growing through adolescence.

8 Sep 2016

Researchers reveal how traditional Chinese medicine helps treat various cancers

Researchers at the University of Adelaide have shown how a complex mix of plant compounds derived from ancient clinical practice in China - a Traditional Chinese Medicine - works to kill cancer cells.

8 Sep 2016

IWGAV establishes strategic recommendations for validating antibody specificity

The International Working Group on Antibody Validation, an independent group of international scientists with diverse research interests in the field of protein biology, today announced the publication of initial strategies developed to address a critical unmet need for antibody specificity, functionality and reproducibility in the September online issue of Nature Methods.

8 Sep 2016

Experimental drug shows promise for stopping melanoma and other forms of cancer

An experimental cancer drug works differently than intended and shows significant promise for stopping melanoma and possibly other forms of cancer, research from the University of Virginia School of Medicine suggests.

7 Sep 2016

New molecular mechanism may explain pain relieving drug’s diverse benefits

Aspirin's ability to reduce the risk of both cardiovascular disease and colon cancer has been a welcome, yet puzzling, attribute of the pain reliever that has been a mainstay in medicine cabinets for more than 100 years.

7 Sep 2016

Researchers unlock genetic code that disrupts response to breast cancer therapy

Scientists may have unlocked the genetic code that determines why many patients with estrogen receptor-positive breast cancer fail to respond to the widely used drug tamoxifen.

7 Sep 2016

New computer program can predict underlying genomics of ER+ breast cancer

The number of tubules in tumors may predict which women with estrogen receptor positive (ER+) breast cancer will benefit from hormone therapy alone and which require chemotherapy, researchers at Case Western Reserve University have found.

7 Sep 2016

Schizophrenia drug slows pancreatic tumor growth in mice

A receptor for the dopamine neurotransmitter promotes growth and spread of pancreatic cancer -- and schizophrenia drugs, which block the function of this receptor, slowed tumor growth and metastatic spread in mice, according to researchers at McGill University and the German Cancer Research Center.

7 Sep 2016

Scientists find link between antimicrobial chemicals and antibiotic-resistance genes in microbes

Antibiotic-resistant bacteria, known as "superbugs," pose a major public health threat.

7 Sep 2016

Cedars-Sinai researchers develop new way to identify patients at risk for aggressive prostate cancer

Scientists at Cedars-Sinai have developed a new way to identify which prostate cancer patients are likely to develop aggressive types of the disease even if their tumors at first appear to be lower risk.

7 Sep 2016

Targeting specific neurons in the brain may provide effective treatment for anxiety

Clinical anxiety affects up to 30 percent of Americans who are in great need of better treatments with fewer side effects.

7 Sep 2016

New drug holds potential for treating advanced mastocytosis

Most people have never heard of mastocytosis. It's a rare, sometimes deadly, immune disorder. Now new research may help those with advanced mastocytosis and possibly many more people, too.

6 Sep 2016

Nanomechanical microcantilevers can quickly detect mutations in patients with malignant melanoma

Changes in the genetic make-up of tissue samples can be detected quickly and easily using a new method based on nanotechnology.

6 Sep 2016

Good blood microcirculation linked to longevity

Human longevity has been previously linked by researchers to genetic factors, calorie restriction, and certain life-style factors such as physical activity or the Mediterranean diet.

6 Sep 2016

Experimental co-culture approach facilitates study of cellular events underlying Huntington's disease

Using an experimental co-culture approach in which two different types of neurons from a mouse model of Huntington's disease (HD) are grown side-by-side, connecting to form critically impacted circuits, researchers at University of California San Diego School of Medicine have identified a subunit of a protein that, when expressed, reverse the mutated gene effects responsible for HD.

6 Sep 2016

Overweight kidney cancer patients live longer than normal-weight counterparts, study shows

Obesity almost always increases cancer risk and worsens outcomes, but researchers led by scientists at Dana-Farber Cancer Institute report that overweight patients with advanced kidney cancer had significantly longer survival than those who were normal or underweight.

6 Sep 2016

HIF-2 inhibitors could be promising target to combat kidney cancer

A new class of drugs called HIF-2 inhibitors is more effective and better tolerated than the standard of care drug sunitinib in treating kidney cancer, researchers with the Kidney Cancer Program at Harold C. Simmons Comprehensive Cancer Center have found.

6 Sep 2016

Gene News and Research

Latest Gene News and Research

Scientists discover potential new genetic causes for intellectual disability

Fruit flies hold clues to how cancerous tumors get started

New mouse model helps identify potential drug target for hard-to-treat social aspects of ASD

Interactions between rare and common genetic variants may contribute to craniosynostosis

Researchers reveal how traditional Chinese medicine helps treat various cancers

IWGAV establishes strategic recommendations for validating antibody specificity

Experimental drug shows promise for stopping melanoma and other forms of cancer

New molecular mechanism may explain pain relieving drug’s diverse benefits

Researchers unlock genetic code that disrupts response to breast cancer therapy

New computer program can predict underlying genomics of ER+ breast cancer

Schizophrenia drug slows pancreatic tumor growth in mice

Scientists find link between antimicrobial chemicals and antibiotic-resistance genes in microbes

Cedars-Sinai researchers develop new way to identify patients at risk for aggressive prostate cancer

Targeting specific neurons in the brain may provide effective treatment for anxiety

New drug holds potential for treating advanced mastocytosis

Nanomechanical microcantilevers can quickly detect mutations in patients with malignant melanoma

Good blood microcirculation linked to longevity

Experimental co-culture approach facilitates study of cellular events underlying Huntington's disease

Overweight kidney cancer patients live longer than normal-weight counterparts, study shows

HIF-2 inhibitors could be promising target to combat kidney cancer

Industry Focus: Cell & Gene Therapy eBook

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research